Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly

Sabina A. Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, Wim A. Wuyts, Marlies S. Wijsenbeek, Antoine Froidure, Elena Bargagli, Elisabetta A. Renzoni, Marcel Veltkamp, Paolo Spagnolo, Hilario Nunes, Cormac McCarthy, Maria Molina-Molina, Francesco Bonella, Venerino Poletti, Michael Kreuter, Katerina M. Antoniou, Catharina C. Moor
ERJ Open Research 2021; DOI: 10.1183/23120541.00640-2021
Sabina A. Guler
1Department of Pulmonary Medicine, Bern University Hospital, University of Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Cuevas-Ocaña
2Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mouhamad Nasser
3Department of Respiratory Medicine, National Reference Center for Rare Pulmonary Diseases, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim A. Wuyts
4Unit for Interstitial Lung Disease, Department of Respiratory Medicine, University Hospitals Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wim A. Wuyts
Marlies S. Wijsenbeek
5Center for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC–University Medical Center Rotterdam, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Froidure
6Service de pneumologie, Cliniques universitaires Saint-Luc and Institut de Recherche Expérimentale, Bruxelles, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Bargagli
7Departement of Medical Sciences, Surgery and Neurosciences, Respiratory Medicine, Siena University, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabetta A. Renzoni
8Interstitial Lung Disease Unit, Royal Brompton and Harefield, part of Guy's and St Tomas’ NHS Foundation Trust, London, Margaret Turner Warwick Centre for Firbosing Lung Diseases, Imperial College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel Veltkamp
9Interstitial Lung Diseases Centre of Excellence, St. Antonius Hospital, P.O. Box 2500, 3430 EM Nieuwegein, The Netherlands
10Division of Heart & Lungs, University Medical Center Utrecht, P.O. Box 85500, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Spagnolo
11Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hilario Nunes
12Service de Pneumologie, Centre de Référence des Maladies Pulmonaires Rares, Hôpital Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Nord, Bobigny, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cormac McCarthy
13UCD School of Medicine, Education and Research Centre, St. Vincent's University Hospital, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Molina-Molina
14Department of Pneumology, Unit of Interstitial Lung Diseases, University Hospital of Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Bonella
15Center for interstitial and rare lung diseases, Ruhrlandklinik University Hospital, Duisburg-Essen University, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Francesco Bonella
Venerino Poletti
16Dipartimento Malattie dell'Apparato Respiratorio e del Torace Ospedale GB Morgagni-Forli' (FC)/University of Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Kreuter
17Center for interstitial and rare lung diseases & Interdisciplinary Center for Sarcoidosis, Pneumology, Thoraxklinik, University Hospital Heidelberg and German Center for Lung Research, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Kreuter
Katerina M. Antoniou
18Laboratory of Molecular & Cellular Pneumonology Laboratory, Department of Respiratory Medicine, School of Medicine, University of Crete, Crete, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catharina C. Moor
5Center for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC–University Medical Center Rotterdam, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Catharina C. Moor
  • For correspondence: c.moor@erasmusmc.nl
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

This article provides an overview of scientific highlights in the field of interstitial lung disease (ILD), presented at the virtual European Respiratory Society Congress 2021. A broad range of topics was discussed this year, ranging from translational and genetic aspects to novel innovations with the potential to improve the patient pathway. Early Career Members summarize a selection of interesting findings from different congress sessions, together with the leadership of Assembly 12 – Interstitial Lung Disease.

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: Sabina A. Guler reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Boehringer Ingelheim and Hoffmann-La Roche. Participation on a Data Safety Monitoring Board or Advisory Board for Boehringer Ingelheim. Disclosures made outside the submitted work.

Conflict of interest: Sara Cuevas Ocaña reports receiving support for attending meetings and/or travel from the ERS. Disclosure made outside the submitted work.

Conflict of interest: Mouhamad Nasser reports receiving consulting fees from Boehringer Ingelheim, AstraZeneca, Hoffman La Roche and Chugai, outside the submitted work.

Conflict of interest: Wim A. Wuyts reports grants or contracts received form Roche, Boehringer Ingelheim, Galapagos, NIH and Fund scientific research Flanders. Disclosures made outside the submitted work.

Conflict of interest: Marlies Wijsenbeek reports receiving grants or contracts from Hoffmann-La Roche and Boehringer Ingelheim. Consulting fees from Roche, Boehringer Ingelheim, Galapagos, Bristol Myers Squibb, Galecto and Respivant. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Boehringer Ingelheim, F. Hoffmann-La, Roche and Novartis. Support for attending meetings and/or travel from Boehringer Ingelheim and F. Hoffmann-La Roche. Participation on a Data Safety Monitoring Board for Savara and Galapagos. Unpaid; Chair of the Idiopathic Interstitial Pneumonia group of the European Respiratory Society; Member of the board of the Netherlands Respiratory Society; Member of the scientific advisory board of the European Idiopathic Pulmonary Fibrosis and related disorders federation; Chair of the educational committee of the European Reference Network for rare Lung Diseases; Advisory board of the Dutch Lungfibrosis and Sarcoidosis patient associations. Disclosures made outside the submitted work.

Conflict of interest: Antoine FROIDURE reports grants or contracts received form Roche and Boehringer Ingelheim. Consulting fees received from Boehringer Ingelheim and Roche. Disclosures made outside the submitted work.

Conflict of interest: Elena Bargagli has nothing to disclose.

Conflict of interest: Elisabetta A. Renzoni reports grants or contracts received form Boehringer Ingelheim. Consulting fees received from Boehringer Ingelheim. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Boehringer Ingelheim, Roche and Chiesi. Support for attending meetings and/or travel received from Boehringer Ingelheim. Disclosures made outside the submitted work.

Conflict of interest: Marcel Veltkamp reports receiving consulting fees from Boehringer Ingelheim. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Chiesi Pharmaceutical. Participation on a Data Safety Monitoring Board or Advisory Board for Boehringer Ingelheim and DSMB COLD study (prof. Annema, Amsterdam UMC). Disclosures made outside the submitted work.

Conflict of interest: PAOLO SPAGNOLO reports grants or contracts received from PPM SERVICES, ROCHE and BOEHRINGER. Consulting fees received from PPM SERVICES, CHIESI, NOVARTIS and PIERIS. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from BOEHRINGER, ROCHE and CHIESI. Support for attending meetings and/or travel received from PPM SERVICES AND BOEHRINGER. Participation on a Data Safety Monitoring Board or Advisory Board for GALAPAGOS. Disclosures made outside the submitted work.

Conflict of interest: Hilario NUNES reports receiving consulting fees received from Boehringer Ingelheim, Roche and Grenentech. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Boehringer Ingelheim, Roche and Grenentech. Support for attending meetings and/or travel received from Boehringer Ingelheim, Roche and Grenentech. Participation on a Data Safety Monitoring Board or Advisory Board for Galapagos and Actelion Pharmaceuticals. Other financial or non-financial interests; Investigator of clinical trial for Sanofi, Gilead, Novartis, Galecto Biotech AB and BMS. Disclosures made outside the submitted work.

Conflict of interest: Cormac McCarthy reports receiving grants or contracts from Boehringer Ingelheim. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Roche Ltd and Aerogen. Support for attending meetings and/or travel received from Boehringer Ingelheim and Rocher. Participation on a Data Safety Monitoring Board or Advisory Board for Savara Inc. Disclosures made outside the submitted work.

Conflict of interest: MARIA MOLINA MOLINA reports grants or contracts received from Roche and Boehringer Ing. Consulting fees received from Esteve-Teijin, Ferrer and Chiesi. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Boehringer Ing. Support for attending meetings and/or travel received from Boehringer Ing. Disclosures made outside the submitted work.

Conflict of interest: Francesco Bonella reports receiving consulting fees from Boehringer Ingelheim and Savara Pharma. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Boehringer Ingelheim, Fujirebio, Galapagos NV and Roche. Support for attending meetings and/or travel received from Boehringer Ingelheim and Roche. Participation on a Data Safety Monitoring Board or Advisory Board for Boehringer Ingelheim, Bristol Myers Squibb, Fujirebio, Galapagos NV, GlaxoSmithKline, Roche and Takeda. Disclosures made outside the submitted work.

Conflict of interest: Venerino Poletti has nothing to disclose.

Conflict of interest: Michael Kreuter reports receiving grants or contracts from Roche and Boehringer Ingelheim. Consulting fees received from Roche, Boehringer Ingelheim and Galapagos. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Roche and Boehringer Ingelheim. ERS Assembly 12. Disclosures made outside the submitted work.

Conflict of interest: Katerina Antoniou reports receiving consulting fees from BI and Roche. Payment of honoraria for lectures, presentations, speakers bureaus manuscript writing or educational events for BI and Roche. Support for attending meetings and/or travel received from BI and Roche. ERS Assembly 12 head. Disclosures made outside the submitted work.

Conflict of interest: Catharina C. Moor has nothing to disclose.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Received November 16, 2021.
  • Accepted December 4, 2021.
  • Copyright ©The authors 2021
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

PreviousNext
Back to top
Vol 8 Issue 2 Table of Contents
ERJ Open Research: 8 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly
Sabina A. Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, Wim A. Wuyts, Marlies S. Wijsenbeek, Antoine Froidure, Elena Bargagli, Elisabetta A. Renzoni, Marcel Veltkamp, Paolo Spagnolo, Hilario Nunes, Cormac McCarthy, Maria Molina-Molina, Francesco Bonella, Venerino Poletti, Michael Kreuter, Katerina M. Antoniou, Catharina C. Moor
ERJ Open Research Jan 2021, 00640-2021; DOI: 10.1183/23120541.00640-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly
Sabina A. Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, Wim A. Wuyts, Marlies S. Wijsenbeek, Antoine Froidure, Elena Bargagli, Elisabetta A. Renzoni, Marcel Veltkamp, Paolo Spagnolo, Hilario Nunes, Cormac McCarthy, Maria Molina-Molina, Francesco Bonella, Venerino Poletti, Michael Kreuter, Katerina M. Antoniou, Catharina C. Moor
ERJ Open Research Jan 2021, 00640-2021; DOI: 10.1183/23120541.00640-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Telemedicine and virtual respiratory care in the era of COVID-19
  • Lung cancer in patients with fibrosing interstitial lung diseases – An overview of current knowledge and challenges
  • Ventilator-associated pneumonia in critically ill patients with COVID-19 infection, a narrative review
Show more Invited review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society